Harmony BiosciencesHRMY
那斯達克 · USD
36.36
+0.45
(+1.25%)
盤中 01/21 10:52 (UTC+8)
01/21 10:52 (UTC+8)
Harmony BiosciencesHRMY
36.36
+0.45
(+1.25%)
財務數據
損益表
- 1.34
- 1.60
- 1.68
- 1.55
- 1.73
- 1.86
- 2.01
- 1.85
- 2.00
- 2.39
- 12.67
- 19.41
- 5.08
- -8.19
- 11.77
- 7.65
- 8.19
- -8.21
- 8.53
- 19.44
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 239,455 | 200,489 | 184,733 | 201,267 | 186,038 | 172,814 | 154,615 | 168,412 | 160,268 | 134,216 |
營業成本 | 59,650 | 38,153 | 31,994 | 54,409 | 42,778 | 32,144 | 27,484 | 43,152 | 32,296 | 25,008 |
營業毛利 | 179,805 | 162,336 | 152,739 | 146,858 | 143,260 | 140,670 | 127,131 | 125,260 | 127,972 | 109,208 |
營業費用 | 114,318 | 114,156 | 96,494 | - | 81,550 | - | 75,098 | 85,064 | 63,463 | 62,306 |
研發費用 | 54,962 | 50,159 | 34,540 | 34,666 | 25,387 | 63,583 | 22,189 | 30,306 | 17,499 | 14,969 |
推銷及管理費用 | 59,356 | 63,997 | 61,954 | 56,465 | 56,163 | 55,731 | 52,909 | 54,758 | 45,964 | 47,337 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 65,487 | 48,180 | 56,245 | 55,727 | 61,710 | 21,356 | 52,033 | 40,196 | 64,509 | 46,902 |
其他收入及費用 | 5,624 | 5,103 | 4,768 | 4,637 | 4,808 | 4,742 | 4,287 | 4,289 | -16,299 | -3,117 |
利息費用 | 3,621 | 3,646 | 3,836 | 4,209 | 4,348 | 4,404 | 4,535 | 4,796 | -3,622 | -310 |
稅前純益 | 67,490 | 49,637 | 57,177 | 56,155 | 62,170 | 21,694 | 51,785 | 39,689 | 51,832 | 44,095 |
所得稅 | 16,625 | 9,861 | 11,617 | 6,680 | 16,077 | 10,103 | 13,451 | 13,082 | 13,371 | 9,795 |
稅後純益 | 50,865 | 39,776 | 45,560 | 49,475 | 46,093 | 11,591 | 38,334 | 26,607 | 38,461 | 34,300 |
基本每股稅後盈餘(元) | 0.88 | 0.69 | 0.79 | 0.87 | 0.81 | 0.20 | 0.68 | 0.46 | 0.64 | 0.57 |
稀釋每股稅後盈餘(元) | 0.87 | 0.68 | 0.78 | 0.85 | 0.79 | 0.20 | 0.67 | 0.45 | 0.63 | 0.57 |
基本平均股數(千股) | 57550.00 | 57469.00 | 57309.00 | 57097.00 | 56870.00 | 56802.00 | 56771.00 | 58320.00 | 59863.00 | 59974.00 |
稀釋平均股數(千股) | 58717.00 | 58427.00 | 58524.00 | 58218.00 | 58103.00 | 57541.00 | 57597.00 | 58853.00 | 60681.00 | 60743.00 |
還原基本每股稅後盈餘(元) | 0.88 | 0.69 | 0.79 | 0.87 | 0.81 | 0.20 | 0.68 | 0.46 | 0.64 | 0.57 |
還原稀釋每股稅後盈餘(元) | 0.87 | 0.68 | 0.78 | 0.85 | 0.79 | 0.20 | 0.67 | 0.45 | 0.63 | 0.57 |
還原基本平均股數(千股) | 57,550 | 57,469 | 57,309 | 57,097 | 56,870 | 56,802 | 56,771 | 58,320 | 59,863 | 59,974 |
還原稀釋平均股數(千股) | 58,717 | 58,427 | 58,524 | 58,218 | 58,103 | 57,541 | 57,597 | 58,853 | 60,681 | 60,743 |
EBITDA(千元) | 76,904 | 58,960 | 66,696 | 66,010 | 72,111 | 31,700 | 62,030 | 50,111 | 54,846 | 49,597 |